[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364461-105":59,"doc-detail-364461-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","anticancer-activity-of-enantiomeric-neplanocins-a-exploring-the-role-of-chirality-in-tumor-suppression","Anticancer Activity of Enantiomeric Neplanocins A - Exploring the Role of Chirality in Tumor Suppression","","Neplanocin A (NPA) is a natural carbocyclic analogue of adenosine with reported antibacterial, antiviral, and anticancer effects, but its anticancer mechanism remains insufficiently defined. The study compares the biological activity of the two enantiomers of NPA across cancerous and non-cancerous cell lines. (-)-NPA shows greater cytotoxicity than synthetic (+)-NPA, although cell-type sensitivity varies. Differences among cancer cell types are examined by analyzing gene expression and gene-specific effects of adenosine-interacting enzymes, supported by bioinformatic interaction analyses and molecular docking. Docking reveals enantiomer-dependent differences in binding energy to key enzymes such as ADK, ADA/ADA2, and SAHH, informing the mechanism of action.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/anticancer-activity-of-enantiomeric-neplanocins-a-exploring-the-role-of-chirality-in-tumor-suppression/364461/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/anticancer-activity-of-enantiomeric-neplanocins-a-exploring-the-role-of-chirality-in-tumor-suppression/364461.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":81},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of the study on enantiomeric neplanocins A?","Question",{"text":112,"@type":113},"To compare how (-)-NPA and (+)-NPA differ in anticancer activity across cancerous and non-cancerous cell types and to explore mechanisms behind those differences.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do the two enantiomers of neplanocin A differ in cytotoxicity?",{"text":117,"@type":113},"Across tested cell lines, (-)-NPA is more cytotoxic than the synthetic (+)-NPA derivative, but sensitivity varies between cell types.",{"name":119,"@type":110,"acceptedAnswer":120},"Which molecular targets and enzymes are analyzed to explain the different activities?",{"text":121,"@type":113},"The work examines expression levels and effects of genes for adenosine-interacting enzymes, including adenosine kinase (ADK), adenosine deaminases (ADA and ADA2), and S-adenosylhomocysteine hydrolase (SAHH/ACHCY), using bioinformatic interaction analysis and molecular docking.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},364461,1792836148,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":81,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","Article  \nAnticancer Activity of Enantiomeric Neplanocins A: Exploring the Role of Chirality in Tumor Suppression  \nRoza Pawlowska *, Hubert Banaszkiewicz , Arkadiusz Chworos  and Remigiusz Z˙urawi ´nski *  \nCentre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, 90-363 Lodz, Poland; [hubert.banaszkiewicz@cbmm.lodz.pl](hubert.banaszkiewicz@cbmm.lodz.pl) (H.B.); [arkadiusz.chworos@cbmm.lodz.pl](arkadiusz.chworos@cbmm.lodz.pl) (A.C.)  \n* Correspondence: [roza.pawlowska@cbmm.lodz.pl](roza.pawlowska@cbmm.lodz.pl) (R.P.); [remigiusz.zurawinski@cbmm.lodz.pl](remigiusz.zurawinski@cbmm.lodz.pl) (R.Z˙ .)  \nAbstract: Neplanocin A (NPA) is a natural carbocyclic analogue of adenosine that was isolated from Ampullariella regularis, which is known for its antibacterial, antiviral, and anticancer activity. Although the activity of this compound has been demonstrated in many biological models, the mechanism of its anticancer activity is not fully understood. In the current work, we present the comparison of the biological activity of two enantiomers of neplanocin A in the series of cancerous and non-cancerous cell types. In all tested cell lines, the compound with natural stereochemistry, (-)-NPA, was found to be more cytotoxic than its synthetic (+)-NPA derivative; however, sensitivity to neplanocins A varied between cell types. To determine possible reasons for the observed differences in individual cancer cell types, the expression level and effects of individual genes of adenosine-interacting enzymes were analyzed. Bioinformatic analysis of the interaction between (-)-NPA and (+)-NPA with major adenosine-interacting enzymes, such as adenosine kinase (ADK), adenosine deaminases (ADA and ADA2), and S-adenosylhomocysteine hydrolase (SAHH, AHCY), was performed. The molecular docking results revealed differences in the binding energy of the individual enantiomers of neplanocin A with the targets, which sheds new light on the mechanism of action of these adenosine analogues.  \nAcademic Editors: Grzegorz Bartoszand Izabela Sadowska-Bartosz  \nReceived: 13 November 2024  \nRevised: 25 January 2025  \nAccepted: 1 February 2025  \nPublished: 4 February 2025  \nCitation: Pawlowska, R.;  \nBanaszkiewicz, H.; Chworos, A.;  \nZ˙ urawi ´nski, R. Anticancer Activity of Enantiomeric Neplanocins A: Exploring the Role of Chirality in Tumor Suppression. Int. J. Mol. Sci. 2025, 26, 1308. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/ijms26031308](10.3390/ijms26031308)  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \nKeywords: neplanocin A; adenosine analogue; chirality; adenosine kinase; adenosine deaminase; S-adenosylhomocysteine hydrolase; molecular docking  \n1. Introduction  \nAdenosine is one of the basic nucleosides present both intra-and extracellularly, which exhibit an anticancer and antioxidant activity [1–4] and may act as a regulator of the immune system [5] . The activity of adenosine in cells is mainly related to its interaction with specific cellular targets such as adenosine kinase (ADK) and adenosine deaminases (ADA and ADA2), which convert it into AMP and inosine, respectively (Figure 1) . As a precursor of ATP, adenosine plays a crucial role in ATP-dependent signaling pathways [6] and RNA synthesis [7] .  \nDue to the wide range of adenosine activity, its derivatives have garnered significant interest as potential therapeutic agents. Adenosine analogues have been explored for a variety of biomedical applications [8,9], including antiproliferative [10] and antioxidant [2] treatments. This class of compounds is being tested as inhibitors of adenosine-binding enzymes [11], ligands for adenosine receptors [8,12","cbCaigtULAbtXWhR","https://ap.wps.com/l/cbCaigtULAbtXWhR","pdf",4493617,16,"English","# Introduction\n## Adenosine functions and targets\n## Adenosine analogues and therapeutic interest\n## Neplanocin A structure and historical background\n## Proposed mechanism involving adenosine-interacting enzymes\n## Prior findings on NPA enantiomers and SAHH/ACHCY inhibition","[{\"question\":\"What is the main goal of the study on enantiomeric neplanocins A?\",\"answer\":\"To compare how (-)-NPA and (+)-NPA differ in anticancer activity across cancerous and non-cancerous cell types and to explore mechanisms behind those differences.\"},{\"question\":\"How do the two enantiomers of neplanocin A differ in cytotoxicity?\",\"answer\":\"Across tested cell lines, (-)-NPA is more cytotoxic than the synthetic (+)-NPA derivative, but sensitivity varies between cell types.\"},{\"question\":\"Which molecular targets and enzymes are analyzed to explain the different activities?\",\"answer\":\"The work examines expression levels and effects of genes for adenosine-interacting enzymes, including adenosine kinase (ADK), adenosine deaminases (ADA and ADA2), and S-adenosylhomocysteine hydrolase (SAHH/ACHCY), using bioinformatic interaction analysis and molecular docking.\"}]","Anticancer Activity of Enantiomeric Neplanocins A - Exploring the Role of Chirality in Tumor Suppression | PDF",1790157628,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4c01d207d38972fb98429e1565df9ec0.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db6bbf16b2009a4101c3ec04a53f46ba.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/663f09aac1403bda0ad1845479b17c47.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/538aa0cb1883909fbd58ca96a59b6a79.webp",980,1385]